Why the DroneShield (ASX:DRO), BrainChip (ASX:BRN) and Recce (ASX:RCE) share prices are rising today

The share prices of these 3 ASX growth shares have all jumped today off the back of recent announcements. All are innovators in their fields.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Today has been very strong for a range of ASX sectors after yesterday's market fall. We've seen the share prices of a number of innovative ASX growth companies rise today, including the 3 listed below.

Red paper plane zooming ahead of an army of white paper plane competition

Image source: Getty Images

DroneShield Ltd (ASX: DRO)

The Droneshield share price is up by 23.33% at time of writing.

The company provides non-ballistic detect and disrupt technology for defending against drones. It recently announced it had obtained funding from the US Department of Defence (DoD) for enhancements to its DroneShieldComplete Command-and-Control (C2) system. Previously, the company had made several announcements. First, relating to sales to 2 European nations, and second, to a successful deployment in a mid-sized European airport. This has also had an impact on the company's share price.

At the conclusion of the project to enhance the DroneShieldComplete C2, the company anticipates selling additional products to the US DoD. DroneShield CEO Oleg Vornik said the project underscored the company's leadership not only as a product/sensor manufacturer, but also as an integrator of fixed site and mobile counter unmanned aircraft systems.

Recce Pharmaceuticals Ltd (ASX: RCE)

Recce (pronounced Recky) is a medical research company developing a new range of synthetic antibiotics. Unlike current approaches, Recce's products kill bacteria instead of inhibiting growth, enabling multiple use without a reduction in potency. 

Today the company announced it has selected South Australia's CMAX Clinical Research as its independent trial facility. The laboratory will conduct a phase I clinical study of Recce's lead compound RECCE 327.

This is a controlled ascending dose study of 48 healthy adult subjects, resulting in an evaluation of the safety and tolerability of the product after intravenous use. In response to the news, the Recce share price has risen by 3.14% at the time of writing. 

Brainchip Holdings Ltd (ASX: BRN)

The BrainChip share price is up by 3.33% at the time of writing, and has risen by 73.33% over the past 5 days.

BrainChip is an artificial intelligence (AI) company that has recently completed construction of the wafer of its newest product, a neuromorphic chip designed to mimic the human brain and sensory system.

The company has announced 2 proof of concept partnerships.

First, with Magik Eye Inc to combine AI with the Magik Eye's 3D sensing. This partnership will be targeting gesture recognition in a wide array of gaming and consumer products. Second, the Brainchip share price jumped 54% after the company announced a partnership with VORAGO Technologies to support a phase 1 project for NASA.

Motley Fool contributor Daryl Mather owns shares of Recce Pharmaceuticals Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Buy, hold, and sell ratings written on signs on a wooden pole.
Opinions

With cash profits jumping to $11 billion, are CBA shares now a buy, hold or sell?

CBA enjoyed a very profitable FY 2026. But is the ASX 200 bank stock a buy for FY 2027?

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Up 73%! 3 reasons I'd still buy Mineral Resources shares today

A leading expert forecasts more outperformance from Mineral Resources surging shares.

Read more »

Friends in a 4WD.
Broker Notes

Following its results, Macquarie is tipping 80% upside for this ASX 300 stock

This parts supplier appears primed for share price growth.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news.
ASX Share Market News

Why CBA, Seek, and AGL shares are turning heads on Wednesday

Investors are rushing to sell up one of these stocks.

Read more »

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.
ASX Share Market News

Imagine the ASX 200 near-tripling in a year. That's what the KOSPI did in FY26

Then came last month's 44% crash. Here's the full story behind the KOSPI's boom and bust.

Read more »

Happy mum and dad with daughter smiling on couch after relocation to new home.
Broker Notes

After crashing 19% this broker says Life360 shares are a buy

Investors should consider buying the dip after yesterday's sell-off.

Read more »

A white and black clock face is shown with Time to Buy written.
Opinions

2 top ASX shares to buy and hold for the next decade

These stocks have a lot to offer long-term investors…

Read more »

Smiling woman with her head and arm on a desk holding $100 notes, symbolising dividends.
ASX Share Market News

2 ASX passive income ideas I'd use to generate $600 a month in 2027

I view these stocks as excellent ideas for income.

Read more »